| 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up J Vansteenkiste, L Crino, C Dooms, JY Douillard, C Faivre-Finn, E Lim, ... Annals of Oncology 25 (8), 1462-1474, 2014 | 535 | 2014 |
| 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer WEE Eberhardt, D De Ruysscher, W Weder, C Le Pechoux, P De Leyn, ... Annals of Oncology 26 (8), 1573-1588, 2015 | 402 | 2015 |
| Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer KM Kerr, L Bubendorf, MJ Edelman, A Marchetti, T Mok, S Novello, ... Annals of Oncology 25 (9), 1681-1690, 2014 | 360 | 2014 |
| 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease B Besse, A Adjei, P Baas, P Meldgaard, M Nicolson, L Paz-Ares, M Reck, ... Annals of Oncology 25 (8), 1475-1484, 2014 | 285 | 2014 |
| Exosomal proteins as diagnostic biomarkers in lung cancer B Sandfeld-Paulsen, KR Jakobsen, R Bæk, BH Folkersen, ... Journal of Thoracic Oncology 11 (10), 1701-1710, 2016 | 269 | 2016 |
| Exosomal proteins as prognostic biomarkers in non-small cell lung cancer B Sandfeld-Paulsen, N Aggerholm-Pedersen, R Bæk, KR Jakobsen, ... Molecular oncology 10 (10), 1595-1602, 2016 | 250 | 2016 |
| Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor‐sensitizing and resistance mutations in the plasma DNA of patients with advanced non–small cell lung … BS Sorensen, L Wu, W Wei, J Tsai, B Weber, E Nexo, P Meldgaard Cancer 120 (24), 3896-3901, 2014 | 216 | 2014 |
| Erlotinib accumulation in brain metastases from non-small cell lung cancer: visualization by positron emission tomography in a patient harboring a mutation in the epidermal … B Weber, M Winterdahl, A Memon, BS Sorensen, S Keiding, L Sorensen, ... Journal of Thoracic Oncology 6 (7), 1287-1289, 2011 | 167 | 2011 |
| Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays B Weber, P Meldgaard, H Hager, L Wu, W Wei, J Tsai, A Khalil, E Nexo, ... BMC cancer 14, 1-6, 2014 | 165 | 2014 |
| Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer L Fokdal, H Honoré, M Høyer, P Meldgaard, K Fode, H von der Maase International Journal of Radiation Oncology* Biology* Physics 59 (2), 436-444, 2004 | 143 | 2004 |
| Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR-mutated non-small cell lung cancer treated with erlotinib SF Sorensen, C Demuth, B Weber, BS Sorensen, P Meldgaard Lung Cancer 100, 77-84, 2016 | 120 | 2016 |
| The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients AA Memon, BS Sorensen, P Meldgaard, L Fokdal, T Thykjaer, E Nexo British journal of cancer 94 (11), 1703-1709, 2006 | 104 | 2006 |
| PD-L1 expression and survival among patients with advanced non–small cell lung cancer treated with chemotherapy SF Sorensen, W Zhou, M Dolled-Filhart, JB Georgsen, Z Wang, ... Translational oncology 9 (1), 64-69, 2016 | 96 | 2016 |
| PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer AA Memon, B Weber, M Winterdahl, S Jakobsen, P Meldgaard, ... British journal of cancer 105 (12), 1850-1855, 2011 | 95 | 2011 |
| Down-regulation of S100C is associated with bladder cancer progression and poor survival AA Memon, BS Sorensen, P Meldgaard, L Fokdal, T Thykjaer, E Nexo Clinical cancer research 11 (2), 606-611, 2005 | 94 | 2005 |
| Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer L Fokdal, M Høyer, P Meldgaard, H von der Maase Radiotherapy and oncology 72 (2), 139-145, 2004 | 77 | 2004 |
| Evaluation of NGS and RT-PCR methods for ALK rearrangement in European NSCLC patients: results from the European Thoracic Oncology Platform Lungscape Project I Letovanec, S Finn, P Zygoura, P Smyth, A Soltermann, L Bubendorf, ... Journal of Thoracic Oncology 13 (3), 413-425, 2018 | 75 | 2018 |
| The blood group ABO gene transcript is down-regulated in human bladder tumors and growth-stimulated urothelial cell lines TF Ørntoft, P Meldgaard, B Pedersen, H Wolf Cancer research 56 (5), 1031-1036, 1996 | 67 | 1996 |
| Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: an expert consensus F Cappuzzo, D Moro-Sibilot, O Gautschi, E Boleti, E Felip, HJM Groen, ... Lung Cancer 87 (2), 89-95, 2015 | 53 | 2015 |
| Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients A Winther-Larsen, C Demuth, J Fledelius, AT Madsen, K Hjorthaug, ... British Journal of Cancer 117 (5), 704-709, 2017 | 47 | 2017 |
Torben Riis RasmussenSenior Consultant, Associate professor, Aarhus UniversityVerified email at rm.dk
